GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (TSE:4540) » Definitions » Cyclically Adjusted PS Ratio

Tsumura (TSE:4540) Cyclically Adjusted PS Ratio : 2.23 (As of Jun. 09, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Tsumura Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Tsumura's current share price is 円3962.00. Tsumura's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円1,776.61. Tsumura's Cyclically Adjusted PS Ratio for today is 2.23.

The historical rank and industry rank for Tsumura's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4540' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.49   Med: 2.03   Max: 3.04
Current: 2.23

During the past years, Tsumura's highest Cyclically Adjusted PS Ratio was 3.04. The lowest was 1.49. And the median was 2.03.

TSE:4540's Cyclically Adjusted PS Ratio is ranked worse than
52.62% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs TSE:4540: 2.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tsumura's adjusted revenue per share data for the three months ended in Mar. 2024 was 円461.213. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円1,776.61 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tsumura Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Tsumura's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura Cyclically Adjusted PS Ratio Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.74 2.49 1.96 1.54 2.14

Tsumura Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.54 1.54 1.59 1.50 2.14

Competitive Comparison of Tsumura's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tsumura's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsumura's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tsumura's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tsumura's Cyclically Adjusted PS Ratio falls into.



Tsumura Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Tsumura's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3962.00/1776.61
=2.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tsumura's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tsumura's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=461.213/107.2000*107.2000
=461.213

Current CPI (Mar. 2024) = 107.2000.

Tsumura Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 377.568 98.000 413.013
201409 369.821 98.500 402.485
201412 458.044 97.900 501.556
201503 360.491 97.900 394.736
201506 379.445 98.400 413.379
201509 394.181 98.500 428.997
201512 453.762 98.100 495.854
201603 369.458 97.900 404.555
201606 406.840 98.100 444.579
201609 392.301 98.000 429.129
201612 448.068 98.400 488.139
201703 392.054 98.100 428.422
201706 422.611 98.500 459.938
201709 424.727 98.800 460.837
201712 431.082 99.400 464.909
201803 352.756 99.200 381.204
201806 389.448 99.200 420.855
201809 372.649 99.900 399.880
201812 441.314 99.700 474.512
201903 377.933 99.700 406.363
201906 401.520 99.800 431.292
201909 393.457 100.100 421.365
201912 434.562 100.500 463.533
202003 366.798 100.300 392.031
202006 371.151 99.900 398.272
202009 373.242 99.900 400.516
202012 411.617 99.300 444.364
202103 365.570 99.900 392.283
202106 415.269 99.500 447.405
202109 413.617 100.100 442.954
202112 457.024 100.100 489.440
202203 407.335 101.100 431.912
202206 449.854 101.800 473.717
202209 466.493 103.100 485.044
202212 483.211 104.100 497.601
202303 431.533 104.400 443.107
202306 486.222 105.200 495.466
202309 500.923 106.200 505.640
202312 533.632 106.800 535.631
202403 461.213 107.200 461.213

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tsumura  (TSE:4540) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Tsumura Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Tsumura's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsumura (TSE:4540) Business Description

Traded in Other Exchanges
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura (TSE:4540) Headlines

No Headlines